文献速递心血管MR

T1 mapping组织异质性无需钆对比剂即可改善扩张型心肌病患者ICD风险分层

T1 Mapping Tissue Heterogeneity Provides Improved Risk Stratification for ICDs Without Needing Gadolinium in Patients With Dilated Cardiomyopathy.
PubMed 文献 · JACC Cardiovasc Imaging · 2020-07-09

本研究前瞻性纳入115例非缺血性扩张型心肌病(NICM)一级预防ICD候选者和55例健康对照,采用1.5T心脏磁共振原生T1 mapping评估心肌组织异质性(Mad-SD)。中位随访24个月,13例(11%)发生主要终点;Mad-SD>0.24与LGE存在对主要终点预测能力相当,联合全局原生T1可提供额外风险分层且无需钆对比剂。

要点

  • 原生T1 mapping的Mad-SD>0.24与LGE存在对心律失常事件预测能力相当(年事件率9.8% vs 10.9%)。
  • Mad-SD联合全局原生T1预测心律失常事件的敏感度85%、特异度72%,C-statistic 0.76。
  • 该方法无需钆对比剂即可为NICM患者一级预防ICD提供额外风险分层。

核心结论

  • 原生T1 mapping联合评估心肌组织异质性和间质纤维化是室性心动过速和心室颤动的重要预测因子,无需钆对比剂即可为NICM患者一级预防ICD提供额外风险分层。

研究设计与样本

  • 前瞻性研究,纳入115例NICM一级预防ICD候选者和55例年龄性别分布相似的健康对照,采用1.5T心脏磁共振,序列包括电影磁共振评估左心室功能、晚期钆增强(LGE)评估局灶性瘢痕、5层原生T1 mapping评估弥漫性纤维化和异质性。

关键影像表现/征象

  • 原生T1 mapping通过节段像素SD与平均像素SD的平均绝对偏差(Mad-SD)评估心肌组织异质性。
  • Mad-SD>0.24与LGE存在对主要终点的预测能力相当(年事件率9.8% vs 10.9%)。
  • Mad-SD联合全局原生T1预测心律失常无事件生存的年事件率为0%。

诊断标准与关键数值

  • Mad-SD>0.24为二分类阈值,对主要终点的预测与LGE存在相当。
  • Mad-SD联合全局原生T1预测心律失常事件:敏感度85%(95%CI 55%-98%),特异度72%(95%CI 62%-80%),C-statistic 0.76(95%CI 0.64-0.87)。
  • 主要终点为适当ICD治疗和心源性猝死的复合终点。

临床应用与阅片要点

  • 原生T1 mapping可无钆对比剂评估心肌组织异质性,用于NICM患者一级预防ICD的风险分层。
  • Mad-SD>0.24与LGE存在对心律失常事件预测能力相当,可作为LGE的补充或替代指标。
  • Mad-SD联合全局原生T1可提高风险分层效能,敏感度85%、特异度72%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study sought to determine whether myocardial tissue heterogeneity scanned by native T1 mapping could improve risk stratification in patients with nonischemic dilated cardiomyopathy (NICM) evaluated for primary prevention by ICD.

BACKGROUND: The benefit of insertable cardiac-defibrillator (ICD) as primary prevention ICD in patients with NICM remains to be fully clarified.

METHODS: A total of 115 NICM candidates for primary prevention and 55 healthy controls with similar distributions of age and sex were prospectively enrolled. Imaging was performed at 1.5-T using a protocol that included cine magnetic resonance for left ventricular function, late gadolinium enhancement (LGE) for focal scarring, and 5-slice native T1 mapping for diffuse fibrosis and heterogeneity. The last method was assessed by mean absolute deviation of the segmental pixel-SD from the average pixel-SD (Mad-SD). The primary endpoint was a composite of appropriate ICD therapy and sudden cardiac death.

RESULTS: During a median follow-up of 24 months, 13 patients (11%) experienced the primary endpoint. Dichotomized Mad-SD >0.24 provided a comparable outcome to the presence of LGE for the primary endpoint (annual event rate: 9.8% vs. 10.9%). The integration of Mad-SD to global native T1 showed excellent arrhythmic event-free survival (annual event rate: 0%), and high sensitivity of 85% (95% confidence interval [CI]: 55% to 98%) and moderate specificity of 72% (95% CI: 62% to 80%), with a C-statistic of 0.76 (95% CI: 0.64 to 0.87), which was comparable to the presence, location, or extent of LGE in its ability to predict arrhythmic events.

CONCLUSIONS: Combined myocardium tissue heterogeneity and interstitial fibrosis assessment by native T1 mapping is an important predictor of ventricular tachycardia and ventricular fibrillation and provides additive risk stratification for primary prevention ICD in NICM patients without the need for gadolinium contrast.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Nakamori S, Ngo LH, Rodriguez J, et al. T1 Mapping Tissue Heterogeneity Provides Improved Risk Stratification for ICDs Without Needing Gadolinium in Patients With Dilated Cardiomyopathy. JACC Cardiovasc Imaging. 2020. PMID: 32653543. doi:10.1016/j.jcmg.2020.03.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。